Senior insider sale
Chief Scientific Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$12.9K
24.83K shares
What this filing means
TAVERAS ARTHUR plans to sell 24.83K shares of X4 PHARMACEUTICALS, INC valued at approximately $12.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/24/2025ACC: 0001973141-25-000040
Officer· Chief Scientific Officer
Since Nov 2020
24.83K
Shares to sell
$12.9K
Approx. market value
24.83K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
PRSU Vesting
N/A
1/23/2025
24.83KTotal acquired24.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2025 | PRSU Vesting N/A | 24.83K | — |
| Total | 24.83K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
24.83K
Market value
$12.9K
1/24/2025
Total
Units
24.83K
Value
$12.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/24/2025 | 24.83K | $12.9K | NASDAQ | Planned |
| Total | 24.83K | $12.9K | ||